On October 7, 2020, Avail Medsystems, the medical technology company pioneering telemedicine for the procedure room (Procedural Telemedicine™), announced that it has raised $100 million in Series B funding led by D1 Capital Partners, with participation from 8VC and existing investors. Wilson Sonsini Goodrich & Rosati represented Avail Medsystems in the transaction.
Avail Medsystems has developed Procedural Telemedicine™ technology that digitizes physical presence and enables HIPAA compliant collaboration among a network of healthcare professionals and industry experts. Its Procedural TelemedicineTM System is built to meet the specific needs of physicians and medical experts for remote collaboration during procedures or for clinical education and training. The system is supported by the Avail Portal, a secure online platform used by a network of medical industry experts and physicians. The Portal allows users to manage schedules, update availability in real time and collaborate and provides tools to support medical device representatives, particularly those in the field, to run their remote activities and their business, including the ability to manage relationships, track historical utilization, and improve time management. The company intends to use the funds to further expand its business reach.
The Wilson Sonsini team that represented Avail Medsystems in the transaction includes:
Corporate
Scott Murano
Brian Appel
Patricia Swen
TTG
Manja Sachet
Patents
Peter Eng
Elaine Lee
Privacy
Matt Staples
Haley Bavasi
Daniel Chen
For more information, please see Avail Medsystems' press release.